M N H International

Posology The daily dose of TAD usually recommended for patients undergoing chemotherapy with cisplatin and related products is 1.5 g/m² (corresponding to 2.5 g) administered by slow intravenous infusion. The dosage, however, is dependent on age, weight and clinical conditions of the patient and should also be related to the dose and the administration schedule of the chemotherapeutic agent. In case of simultaneous administration of glutathione and the chemotherapeutic agent, the intravenous infusion of TAD should be performed 15-30 minutes before the start of chemotherapy. In case of long term treatments, the lower dosages of the product can be employed (600 mg) to be administered by the intramuscular route or slowly by the intravenous route.